Nucleai Revenue and Competitors

Ultimately what makes us tick is improving people lives. Nucleai is an AI healthcare startup in the field of pathology. Our mission, expertise, and passion are to improve cancer diagnostics. We aim to make biopsy interpretations accurate, efficient, and accessible in order to improve the current standard of care in the field of oncology and to expedite the development of novel cancer treatments. We use the tools that we have mastered- machine learning, deep learning, and machine vision. We work with physicians and for physicians. Nucleai was founded by highly skilled artificial intelligence experts, with previous experience in running an AI and data science R&D department. Nucleai is supported by leading pathologists in Israel and in the US. Nucleai is Backed by top-tier Israeli VC (@Vertex Ventures and @Grove Ventures) and private investors (Nir Kalkstein | Medial EarlySign and Brian Cooper | Retalix). We believe in hard teamwork of bright and devoted people who are constantly improving both as individuals and as a company. We are Team Nucleai